4HVI

JAK3 kinase domain in complex with 2-Cyclopropyl-5H-pyrrolo[2,3-b]pyrazine-7-carboxylic acid ((R)-1-methyl-2-oxo-2-piperidin-1-yl-ethyl)-amide


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.4 Å
  • R-Value Free: 0.303 
  • R-Value Work: 0.235 

wwPDB Validation 3D Report Full Report


This is version 1.1 of the entry. See complete history

Literature

3-Amido Pyrrolopyrazine JAK Kinase Inhibitors: Development of a JAK3 vs JAK1 Selective Inhibitor and Evaluation in Cellular and in Vivo Models.

Soth, M.Hermann, J.C.Yee, C.Alam, M.Barnett, J.W.Berry, P.Browner, M.F.Frank, K.Frauchiger, S.Harris, S.He, Y.Hekmat-Nejad, M.Hendricks, T.Henningsen, R.Hilgenkamp, R.Ho, H.Hoffman, A.Hsu, P.Y.Hu, D.Q.Itano, A.Jaime-Figueroa, S.Jahangir, A.Jin, S.Kuglstatter, A.Kutach, A.K.Liao, C.Lynch, S.Menke, J.Niu, L.Patel, V.Railkar, A.Roy, D.Shao, A.Shaw, D.Steiner, S.Sun, Y.Tan, S.L.Wang, S.Vu, M.D.

(2013) J.Med.Chem. 56: 345-356

  • DOI: 10.1021/jm301646k
  • Primary Citation of Related Structures:  4HVD, 4HVG, 4HVH

  • PubMed Abstract: 
  • The Janus kinases (JAKs) are involved in multiple signaling networks relevant to inflammatory diseases, and inhibition of one or more members of this class may modulate disease activity or progression. We optimized a new inhibitor scaffold, 3-amido-5 ...

    The Janus kinases (JAKs) are involved in multiple signaling networks relevant to inflammatory diseases, and inhibition of one or more members of this class may modulate disease activity or progression. We optimized a new inhibitor scaffold, 3-amido-5-cyclopropylpyrrolopyrazines, to a potent example with reasonable kinome selectivity, including selectivity for JAK3 versus JAK1, and good biopharmaceutical properties. Evaluation of this analogue in cellular and in vivo models confirmed functional selectivity for modulation of a JAK3/JAK1-dependent IL-2 stimulated pathway over a JAK1/JAK2/Tyk2-dependent IL-6 stimulated pathway.


    Organizational Affiliation

    Hoffmann-La Roche, 340 Kingsland Street, Nutley, New Jersey 07110, USA. michael.soth@roche.com




Macromolecules

Find similar proteins by: Sequence  |  Structure

Entity ID: 1
MoleculeChainsSequence LengthOrganismDetails
Tyrosine-protein kinase JAK3
A
314Homo sapiensGene Names: JAK3
EC: 2.7.10.2
Find proteins for P52333 (Homo sapiens)
Go to Gene View: JAK3
Go to UniProtKB:  P52333
Small Molecules
Ligands 1 Unique
IDChainsName / Formula / InChI Key2D Diagram3D Interactions
19S
Query on 19S

Download SDF File 
Download CCD File 
A
2-cyclopropyl-N-[(2R)-1-oxo-1-(piperidin-1-yl)propan-2-yl]-5H-pyrrolo[2,3-b]pyrazine-7-carboxamide
C18 H23 N5 O2
STEKXUJMQOKLQV-LLVKDONJSA-N
 Ligand Interaction
External Ligand Annotations 
IDBinding Affinity (Sequence Identity %)
19SIC50: 69 nM (99) BINDINGDB
19SIC50: 68.9 nM BINDINGMOAD
19SIC50: 68.9 nM PDBBIND
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.4 Å
  • R-Value Free: 0.303 
  • R-Value Work: 0.235 
  • Space Group: P 21 21 21
Unit Cell:
Length (Å)Angle (°)
a = 47.094α = 90.00
b = 75.741β = 90.00
c = 89.915γ = 90.00
Software Package:
Software NamePurpose
ADSCdata collection
HKL-2000data scaling
REFMACrefinement
HKL-2000data reduction
REFMACphasing

Structure Validation

View Full Validation Report or Ramachandran Plots



Entry History 

Deposition Data

Revision History 

  • Version 1.0: 2013-01-16
    Type: Initial release
  • Version 1.1: 2013-01-30
    Type: Database references